ATE380467T1 - Expression von ausgeschiedenem, menschlichem alpha-fetoprotein in transgenen tieren - Google Patents

Expression von ausgeschiedenem, menschlichem alpha-fetoprotein in transgenen tieren

Info

Publication number
ATE380467T1
ATE380467T1 AT00903133T AT00903133T ATE380467T1 AT E380467 T1 ATE380467 T1 AT E380467T1 AT 00903133 T AT00903133 T AT 00903133T AT 00903133 T AT00903133 T AT 00903133T AT E380467 T1 ATE380467 T1 AT E380467T1
Authority
AT
Austria
Prior art keywords
fetoprotein
expression
human alpha
transgenic animals
excreted human
Prior art date
Application number
AT00903133T
Other languages
English (en)
Inventor
Stace Lindsay
Robert Mulroy
Daniel Semeniuk
Original Assignee
Merrimack Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrimack Pharmaceuticals Inc filed Critical Merrimack Pharmaceuticals Inc
Application granted granted Critical
Publication of ATE380467T1 publication Critical patent/ATE380467T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0275—Genetically modified vertebrates, e.g. transgenic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4715—Pregnancy proteins, e.g. placenta proteins, alpha-feto-protein, pregnancy specific beta glycoprotein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Diabetes (AREA)
  • Wood Science & Technology (AREA)
  • Environmental Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Reproductive Health (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Animal Husbandry (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
AT00903133T 1999-01-06 2000-01-06 Expression von ausgeschiedenem, menschlichem alpha-fetoprotein in transgenen tieren ATE380467T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11499599P 1999-01-06 1999-01-06

Publications (1)

Publication Number Publication Date
ATE380467T1 true ATE380467T1 (de) 2007-12-15

Family

ID=22358708

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00903133T ATE380467T1 (de) 1999-01-06 2000-01-06 Expression von ausgeschiedenem, menschlichem alpha-fetoprotein in transgenen tieren

Country Status (10)

Country Link
US (3) US20110077208A1 (de)
EP (2) EP1958503A3 (de)
JP (1) JP2002534077A (de)
AT (1) ATE380467T1 (de)
AU (1) AU2492400A (de)
CA (1) CA2354638C (de)
DE (1) DE60037397T2 (de)
DK (1) DK1148779T3 (de)
ES (1) ES2298127T3 (de)
WO (1) WO2000040693A2 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7208576B2 (en) 1999-01-06 2007-04-24 Merrimack Pharmaceuticals, Inc. Non-glycosylated human alpha-fetoprotein, methods of production, and uses thereof
US7022892B1 (en) 1999-07-12 2006-04-04 Universite Libre De Bruxelles Non-human genetically modified mammal lacking the alpha-fetoprotein
WO2001003501A2 (en) * 1999-07-12 2001-01-18 Universite Libre De Bruxelles Non-human genetically modified mammal lacking the alpha-fetoprotein
AU2002353374A1 (en) * 2001-12-21 2003-07-09 Nexia Biotechnologies, Inc. Production of butyrylcholinesterases in transgenic mammals
CA2784861A1 (en) 2009-12-21 2011-07-14 Pharmathene, Inc. Recombinant butyrylcholinesterases and truncates thereof
CN102526389A (zh) * 2012-03-09 2012-07-04 王利伟 一种治疗肌无力肌萎缩的中药
TW201512001A (zh) * 2013-09-30 2015-04-01 Hon Hai Prec Ind Co Ltd 安全駕駛監控系統、方法及車

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4873292A (en) 1984-12-28 1989-10-10 Research Development Corporation Of Japan Antithrombogenic synthetic polymer and process for its preparation
EP0264166B1 (de) * 1986-04-09 1996-08-21 Genzyme Corporation Genetisch transformierte Tiere, die ein gewünschtes Protein in Milch absondern
US5322775A (en) 1986-06-30 1994-06-21 Pharmaceutical Proteins Ltd. Peptide production
GB8615942D0 (en) * 1986-06-30 1986-08-06 Animal & Food Research Council Peptide production
US4873316A (en) 1987-06-23 1989-10-10 Biogen, Inc. Isolation of exogenous recombinant proteins from the milk of transgenic mammals
JPH0246284A (ja) * 1988-07-25 1990-02-15 Sclavo Spa ヒトα−フェトプロテインの製法
AU6505690A (en) * 1989-09-26 1991-04-28 Richard R Behringer Erythroid-specific gene expression system
US5633076A (en) 1989-12-01 1997-05-27 Pharming Bv Method of producing a transgenic bovine or transgenic bovine embryo
US5831141A (en) 1991-01-11 1998-11-03 United States Of America As Represented By The Department Of Health And Human Services Expression of a heterologous polypeptide in mammary tissue of transgenic non-human mammals using a long whey acidic protein promoter
CA2099562C (en) 1991-01-11 2010-04-20 William N. Drohan Expression of active human protein c in mammary tissue of transgenic animals
AU669484B2 (en) 1991-07-31 1996-06-13 Peri Development Applications (1985) Ltd Transgenic protein production
CA2120131A1 (en) 1991-09-27 1994-05-11 Robert A. Murgita Expression and purification of cloned human alpha-fetoprotein
US5667839A (en) * 1993-01-28 1997-09-16 Collagen Corporation Human recombinant collagen in the milk of transgenic animals
DK75393D0 (da) * 1993-06-24 1993-06-24 Symbicom Ab Production of protein
US5804407A (en) * 1993-11-04 1998-09-08 University Technologies International, Inc. Method of expressing genes in mammalian cells
US5827690A (en) 1993-12-20 1998-10-27 Genzyme Transgenics Corporatiion Transgenic production of antibodies in milk
US5639940A (en) 1994-03-03 1997-06-17 Pharmaceutical Proteins Ltd. Production of fibrinogen in transgenic animals
FR2717500A1 (fr) * 1994-03-17 1995-09-22 Pasteur Institut Procédé d'infection de cellules rénales par un un vecteur recombinant.
GB9406974D0 (en) * 1994-04-08 1994-06-01 Pharmaceutical Proteins Ltd Transgenic production
US5533976A (en) 1994-07-15 1996-07-09 Allergan, Inc. Reusable cartridge assembly for a phaco machine
US5880327A (en) * 1994-09-21 1999-03-09 American National Red Cross Transgenic mammals expressing human coagulation factor VIII
US5780009A (en) 1995-01-20 1998-07-14 Nexia Biotechnologies, Inc. Direct gene transfer into the ruminant mammary gland
AU700975B2 (en) * 1995-01-24 1999-01-14 Merrimack Pharmaceuticals, Inc. Recombinant human alpha-fetoprotein and uses thereof
US5843705A (en) 1995-02-21 1998-12-01 Genzyme Transgenic Corporation Transgenically produced antithrombin III
US5824543A (en) * 1995-06-05 1998-10-20 New York University Method for expression and isolation of biologically active molecules in urine using a mouse uroplakin-II promoter
US6118045A (en) * 1995-08-02 2000-09-12 Pharming B.V. Lysosomal proteins produced in the milk of transgenic animals
US6268487B1 (en) * 1996-05-13 2001-07-31 Genzyme Transgenics Corporation Purification of biologically active peptides from milk
JPH1084981A (ja) * 1996-07-26 1998-04-07 Y S New Technol Kenkyusho:Kk 乳腺発現用ベクター
JP2001522230A (ja) * 1997-02-14 2001-11-13 アメリカン・レツド・クロス トランスジェニック動物乳房組織における活性ヒト第▲ｉｘ▼因子の発現
EP1112353A2 (de) * 1998-09-16 2001-07-04 Nexia Biotechnologies, Inc. Herstellung von rekombinanten proteinen in urin

Also Published As

Publication number Publication date
AU2492400A (en) 2000-07-24
EP1148779A2 (de) 2001-10-31
DE60037397D1 (de) 2008-01-24
ES2298127T3 (es) 2008-05-16
CA2354638A1 (en) 2000-07-13
DE60037397T2 (de) 2008-06-05
CA2354638C (en) 2013-03-19
DK1148779T3 (da) 2008-03-25
EP1958503A2 (de) 2008-08-20
JP2002534077A (ja) 2002-10-15
EP1148779B1 (de) 2007-12-12
EP1958503A3 (de) 2008-11-26
US20110077208A1 (en) 2011-03-31
US20130131317A1 (en) 2013-05-23
WO2000040693A2 (en) 2000-07-13
WO2000040693A3 (en) 2000-09-28
US20120259093A1 (en) 2012-10-11
EP1148779A4 (de) 2003-02-12

Similar Documents

Publication Publication Date Title
ATE237234T1 (de) Haustierfutter geeignet zur zahnpflege der haustiere
DK1252184T3 (da) Human C1-inhibitor produceret i mælk af transgene dyr
NO902446L (no) Dyrefor og fremgangsmaater for deres fremstilling.
DK0915909T3 (da) Insektdræbende proteintoksiner fra Xenorhabdus
BR0001826B1 (pt) fralda descartÁvel.
DE69725052D1 (de) Verbindungsstift für mehrteiliges orthopädisches Implantat
DE69528180T2 (de) Modifiziertes molkeprotein
ATE380467T1 (de) Expression von ausgeschiedenem, menschlichem alpha-fetoprotein in transgenen tieren
BR0001216B1 (pt) fralda descartÁvel.
BR0000687B1 (pt) peÇa Íntima descartÁvel.
BR0012357B1 (pt) elevador de colheitas.
FR2712487B1 (fr) Substitut au capiton plantaire humain.
BR0014527A (pt) Proteìnas de fusão produzidas transgenicamente
ATE139541T1 (de) Kollagen-bindendes protein sowie dessen herstellung
ATE301713T1 (de) Plazentaprotein 13
DK1171470T3 (da) Antistoffer over for placentaprotein 13
LU90560B1 (fr) B-timent d'-levage d'animaux - ventelles
DZ2803A1 (fr) Polypeptide de la protéine c humaine.
FR2769174B1 (fr) Matelas pour animaux
FR2765476B1 (fr) Cocon funeraire
DE50209259D1 (de) Tierstreu
FI3148U1 (fi) Kotieläinten hautausarkku
ATE101487T1 (de) Selbsttaetige tierbehandlung.
KR970026510U (ko) 목초 수확기
ES1033328Y (es) Animnal contorsionable de juguete.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties